You are here

Article info

Article menu
Download PDFPDF
Looking at clinical trials and more
Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?

Authors

  1. Tore K Kvien, Department of Rheumatology, Diakonhjemmet Hospital, Box 23 Vinderen, N-0319 Oslo, Norway; t.k.kvien{at}medisin.uio.no
View Full Text

Citation

Kvien TK, Heiberg T, Hagen KB
Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?
Annals of the Rheumatic Diseases 2007;66:iii40-iii41.

Publication history

  • Accepted July 25, 2007
  • First published October 12, 2007.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2007 BMJ Publishing Group and European League Against Rheumatism